Cardurion
formerly Cardurion PharmaceuticalsChanging the Course of Cardiovascular Disease.
Burlington, United States · Founded 2017 · $820.0M raised
- Headquarters
- Burlington, Massachusetts
- Employees
- 11–50
- Founded
- 2017
- Business Model
- B2B
- Website
- cardurion.com
- Total Funding
- $820.0M
- Last Round
- $260.0M Series BJul 2024
- Rounds
- 10
About
Cardurion Pharmaceuticals is a clinical-stage biotechnology company pioneering next-generation therapeutics for cardiovascular disease. The company has two active clinical programs: a PDE9 inhibitor (CRD-750) in Phase 2 trials for heart failure, and a CaMKII inhibitor for rare arrhythmias including catecholaminergic polymorphic ventricular tachycardia (CPVT) and broader cardiovascular indications. Founded by physician-scientist Dr. Michael E. Mendelsohn, Cardurion is backed by Bain Capital Life Sciences, headquartered in Burlington, Massachusetts with a research affiliate in Japan.
Summary
Cardurion is a Biotech company based in Burlington, United States, founded in 2017. It has raised $820.0M in total across 10 rounds, most recently a $260.0M Series B round in Jul 2024. Investors include Polaris Partners, Bain Capital Life Sciences and Ascenta Capital.
Tech & App Stack
5 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Jul 2024
Sign up to see all 10 rounds
Series A through Series B — per-round amounts, valuations, and who invested in each round.
Investors
Polaris Partners
4 rounds
Bain Capital Life Sciences
3 rounds
.png)
Ascenta Capital
2 rounds
GV
2 rounds
Bain Capital Private Equity
1 round
Takeda (JP)
1 round
NEA
2 rounds
Millennium Management
2 rounds
Farallon Capital
2 rounds
Fidelity Management
2 rounds
Invus
1 round
Blue Owl Capital
1 round
GV (Google Ventures)
1 round
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/cardurion"><img src="https://indexed.vc/api/badge/company/cardurion" alt="Cardurion on Indexed.vc" width="260" height="76" /></a>